{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:24:54Z","timestamp":1790490294575,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21342017"],"award-info":[{"award-number":["21342017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"\u201cExcellent Young Talents Support Program\u201d and Science & Technology Fund Planning Project","award":["2016XC078"],"award-info":[{"award-number":["2016XC078"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.colsurfb.2018.01.008","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T14:52:32Z","timestamp":1515509552000},"page":"11-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori"],"prefix":"10.1016","volume":"164","author":[{"given":"Min","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Yang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Wei","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Bing","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-Le","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2018.01.008_bib0005","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.canlet.2013.08.016","article-title":"Helicobacter pylori-induced gastric inflammation and gastric cancer","volume":"345","author":"Wang","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0010","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.3748\/wjg.v20.i18.5191","article-title":"History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer","volume":"20","author":"Graham","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0015","first-page":"447","article-title":"Formulation and in-vitro evaluation of pH-sensitive oil entrapped polymeric blend amoxicillin beads for the eradication of Helicobacter pylori,","volume":"11","author":"Tripathi","year":"2012","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0020","doi-asserted-by":"crossref","first-page":"17600","DOI":"10.1073\/pnas.1418230111","article-title":"In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation","volume":"111","author":"Thamphiwatana","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0025","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.2147\/DDDT.S136240","article-title":"Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection","volume":"11","author":"Mascellino","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0030","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.actbio.2010.08.028","article-title":"Development of novel nanoparticles shelled with heparin for berberine delivery to treat H. pylori","volume":"7","author":"Chang","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejim.2012.07.006","article-title":"Standard triple and sequential therapies for Helicobacter pylori eradication: an update","volume":"24","author":"Zullo","year":"2013","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0040","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"European Helicobacter study group, management of Helicobacter pylori infection-the maastricht IV\/florence consensus report","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/10611860310001647771","article-title":"Receptor mediated targeting of lectin conjugated gliadin nanoparticle in the treatment of Helicobacter pylori","volume":"11","author":"Umamaheswari","year":"2003","journal-title":"J. Drug Target."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0050","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jmmm.2009.02.087","article-title":"Development of a magnetic system for the treatment of Helicobacter pylori infections","volume":"321","author":"Silva","year":"2009","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0055","first-page":"7","article-title":"Formulation and evaluation pH stimuli sensitive multiparticulate delivery system of clarithromycin for the treatment of Helicobacter pylori","volume":"5","author":"Tripathi","year":"2013","journal-title":"Int. J. PharmTech Res."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0060","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1211\/0022357991772952","article-title":"Evaluation of the factors influencing stomach-specific delivery of antibacterial agents for Helicobacter pylori infection","volume":"51","author":"Shah","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jconrel.2004.06.006","article-title":"Receptor-mediated targeting of lipobeads bearing acetohydroxamic acid for eradication of Helicobacter pylori","volume":"99","author":"Umamaheshwari","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0168-3659(98)00066-2","article-title":"A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitro evaluation","volume":"57","author":"Yang","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0075","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jac\/48.6.923","article-title":"Localization of [14C] amoxicillin in rat gastric tissue when administered with lansoprazole and clarithromycin","volume":"48","author":"Endo","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2014.06.020","article-title":"Eradication of Helicobacter pylori: past, present and future","volume":"189","author":"Lopes","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jac\/dkf097","article-title":"Localization of [14C] clarithromycin in rat gastric tissue when administered with lansoprazole and amoxicillin","volume":"50","author":"Endo","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0090","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0016-5085(89)80057-5","article-title":"Campylobacter pylori and peptic ulcer disease","volume":"96","author":"Graham","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0095","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3748\/wjg.v10.i5.747","article-title":"Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection","volume":"10","author":"Guo","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0100","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1136\/gut.2006.091272","article-title":"Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe","volume":"55","author":"Koletzko","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0105","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1572-0241.2007.01085.x","article-title":"Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics","volume":"102","author":"de Bortoli","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0110","first-page":"9321","article-title":"Gastroretentive drug delivery systems for the treatment of Helicobacter pylori","volume":"20","author":"Zhao","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0115","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.biomaterials.2009.02.036","article-title":"Development of pH-responsive chitosan\/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy","volume":"30","author":"Lin","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0120","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.addr.2013.07.011","article-title":"Nanotechnology as a therapeutic tool to combat microbial resistance","volume":"65","author":"Pelgrift","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2005.10.031","article-title":"Gastroretentive dosage forms: overview and special case of Helicobacter pylori","volume":"111","author":"Bardonnet","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0130","doi-asserted-by":"crossref","first-page":"9091","DOI":"10.1021\/acs.langmuir.7b02043","article-title":"Cisplatin-mediated formation of polyampholytic chitosan nanoparticles with attenuated viscosity and pH-sensitive drug release","volume":"33","author":"Kang","year":"2017","journal-title":"Langmuir"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0169-409X(00)00123-X","article-title":"Polysaccharide colloidal particles as delivery systems for macromolecules","volume":"47","author":"Janes","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/nano.2006.1.2.117","article-title":"Chitosan nanoparticles for oral drug and gene delivery","volume":"1","author":"Bowman","year":"2006","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0145","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v22.i5.10","article-title":"Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies","volume":"2","author":"Galindo-Rodriguez","year":"2005","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0150","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/jps.2600740408","article-title":"Bioadhesive polymers as platforms for oral controlled drug delivery III: oral delivery of chlorothiazide using a bioadhesive polymer","volume":"74","author":"Longer","year":"1985","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0155","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.biomaterials.2016.01.045","article-title":"Design and evaluation of novel pH-sensitive ureido-conjugated chitosan\/TPP nanoparticles targeted to Helicobacter pylori","volume":"84","author":"Jing","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0160","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.colsurfb.2015.02.043","article-title":"Biodegradable polymeric nanoparticles for oral delivery of epirubicin: in vitro, ex vivo, and in vivo investigations","volume":"128","author":"Tariq","year":"2015","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0165","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.2147\/IJN.S141069","article-title":"Vaccination with poly(D, L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNF\u03b1-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis","volume":"12","author":"Margaroni","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0170","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1039\/C7TB01370A","article-title":"Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models","volume":"5","author":"Tian","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0175","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.colsurfb.2012.10.063","article-title":"Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures","volume":"103","author":"Chronopoulou","year":"2013","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0180","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.carbpol.2009.12.040","article-title":"Preparation of poly(lactic acid)\/chitosan nanoparticles for anti-HIV drug delivery applications","volume":"80","author":"Dev","year":"2010","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0185","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1208\/s12249-013-9943-3","article-title":"Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery","volume":"14","author":"Wang","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0190","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.colsurfb.2015.07.081","article-title":"Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy","volume":"135","author":"Xiao","year":"2015","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0195","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/jps.21612","article-title":"Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres","volume":"98","author":"Xu","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0200","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jconrel.2008.01.017","article-title":"Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres","volume":"127","author":"Xu","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2018.01.008_bib0205","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1126\/science.287.5452.482","article-title":"A H+-gated urea channel: the link between Helicobacter pylori urease and gastric colonization","volume":"287","author":"Weeks","year":"2000","journal-title":"Science"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776518300080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776518300080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T05:42:25Z","timestamp":1565329345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776518300080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":41,"alternative-id":["S0927776518300080"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2018.01.008","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2018.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}